Back
UroGen Pharma Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
43
URGN
UroGen Pharma
Last Price:
11.36
Seasonality Move:
5.08%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...UroGen Pharma Price Quote
$11.36
-0.11 (-0.96%)
(Updated: December 13, 2024 at 5:55 PM ET)
UroGen Pharma Key Stats
Sell
43
UroGen Pharma (URGN)
is a Sell
Day range:
$11.24 - $11.68
52-week range:
$10.60 - $20.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.80
P/B ratio:
18.97%
Volume:
325.3K
Avg. volume:
416.7K
1-year change:
-23.79%
Market cap:
$484M
Revenue:
$82.7M
EPS:
$-3.09
How Much Does UroGen Pharma Make?
-
How Much Are UroGen Pharma's Sales Annually?
URGN Revenues are $82.7M -
How Much Profit Does UroGen Pharma's Make A Year?
URGN net income is -$102.2M
Is UroGen Pharma Growing As A Company?
-
What Is UroGen Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.21% -
What Is UroGen Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
UroGen Pharma Stock Price Performance
-
Did UroGen Pharma Stock Go Up Last Month?
UroGen Pharma share price went down by -7.13% last month -
Did URGN's Share Price Rise Over The Last Year?
URGN share price fell by -23.79% over the past 1 year
What Is UroGen Pharma 52-Week High & Low?
-
What Is UroGen Pharma’s 52-Week High Share Price?
UroGen Pharma has traded as high as $20.70 over the past 52 weeks -
What Is UroGen Pharma’s 52-Week Low Share Price?
UroGen Pharma has traded as low as $10.60 over the past 52 weeks
UroGen Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy UroGen Pharma?
-
How Much Debt Does UroGen Pharma Have?
Total long term debt quarterly is $121.7M -
How Much Cash Does UroGen Pharma Have?
Cash and short term investments quarterly total is $249.6M -
What Is UroGen Pharma’s Book Value Per Share?
Book value per share is 0.60
Is UroGen Pharma Cash Flow Positive?
-
What Is URGN Cash Flow From Operations?
Cash flow from operations (TTM) is -$96.1M -
What Is UroGen Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $194.6M -
What Is UroGen Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$92.6M
UroGen Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
URGN return on invested capital is -136.49% -
What Is UroGen Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -49.89% -
What Is URGN Return On Equity?
ROE is a measure of profitability and is 0%
UroGen Pharma Earnings Date & Stock Price
-
What Is UroGen Pharma's Stock Price Today?
A single share of URGN can be purchased today for 11.47 -
What Is UroGen Pharma’s Stock Symbol?
UroGen Pharma trades on the nasdaq under the ticker symbol: URGN -
When Is UroGen Pharma’s Next Earnings Date?
The next quarterly earnings date for UroGen Pharma is scheduled on March 14, 2025 -
When Is URGN's next ex-dividend date?
UroGen Pharma's next ex-dividend date is December 14, 2024 -
How To Buy UroGen Pharma Stock?
You can buy UroGen Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
UroGen Pharma Competitors
-
Who Are UroGen Pharma's Competitors?
Below is a list of companies who compete with UroGen Pharma or are related in some way:
UroGen Pharma Dividend Yield
-
What Is URGN Dividend Yield?
UroGen Pharma’s dividend yield currently is 0% -
What Is UroGen Pharma’s Payout Ratio?
UroGen Pharma’s payout ratio is 0% -
When Did UroGen Pharma Last Pay A Dividend?
The latest dividend pay date is December 14, 2024 -
What Is UroGen Pharma’s Dividend Per Share?
UroGen Pharma pays a dividend of $0.00 per share
UroGen Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 32.69% |
| Revenue: | 20.87% | 4.13% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 39.93 |
| Upside from Last Price: | 248.11% |